• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤病学中的药物治疗。

Drug therapies in dermatology.

机构信息

Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester, UK;

出版信息

Clin Med (Lond). 2014 Feb;14(1):47-53. doi: 10.7861/clinmedicine.14-1-47.

DOI:10.7861/clinmedicine.14-1-47
PMID:24532745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5873621/
Abstract

This article explores the current and emerging therapies for skin disease, with a particular focus on chronic plaque psoriasis and metastatic malignant melanoma. We discuss the current biological therapies used for psoriasis and those on the horizon, including small molecules and biosimilars. We also summarise the recent advances in the use of novel therapeutic agents in other dermatological diseases and outline the promise of translational research and stratified medicine approaches in dermatology. Better matching of patients with therapies is anticipated to have a major effect on both clinical practice and the development of new drugs and diagnostics.

摘要

本文探讨了皮肤病的现有和新兴疗法,特别关注慢性斑块状银屑病和转移性恶性黑色素瘤。我们讨论了目前用于银屑病的生物疗法和即将出现的疗法,包括小分子药物和生物类似药。我们还总结了新型治疗药物在其他皮肤科疾病中的最新应用进展,并概述了转化研究和皮肤科分层医学方法的前景。预计将患者与疗法更好地匹配,将对临床实践以及新药和诊断方法的开发产生重大影响。

相似文献

1
Drug therapies in dermatology.皮肤病学中的药物治疗。
Clin Med (Lond). 2014 Feb;14(1):47-53. doi: 10.7861/clinmedicine.14-1-47.
2
Dermatology update: The dawn of targeted treatment.皮肤病学进展:靶向治疗的曙光。
Cleve Clin J Med. 2015 May;82(5):309-20. doi: 10.3949/ccjm.82gr.15002.
3
A report from the 22nd Congress of the European Academy of Dermatology and Venereology (October 2-6, 2013 - Istanbul, Turkey).欧洲皮肤病与性病学会第22届大会报告(2013年10月2日至6日——土耳其伊斯坦布尔)。
Drugs Today (Barc). 2013 Oct;49(10):667-77. doi: 10.1358/dot.2013.49.10.2076505.
4
Review of Targeted Therapies for Periocular Tumors.眼周肿瘤的靶向治疗综述
Int Ophthalmol Clin. 2017 Winter;57(1):153-168. doi: 10.1097/IIO.0000000000000149.
5
New therapies in pediatric dermatology.儿科皮肤病学的新疗法。
Curr Opin Pediatr. 2011 Aug;23(4):399-402. doi: 10.1097/MOP.0b013e3283483ecf.
6
[Dermatologic treatment. The Danish Society of Dermatology].[皮肤病治疗。丹麦皮肤病学会]
Ugeskr Laeger. 2003 Mar 17;165(12):1228.
7
[Cytokines: current status and prospects in the treatment of skin tumors].[细胞因子:皮肤肿瘤治疗的现状与前景]
Hautarzt. 2001 Aug;52(8):691-6. doi: 10.1007/s001050170082.
8
Methotrexate and its uses in dermatology.甲氨蝶呤及其在皮肤科的应用。
Med Times. 1970 Jun;98(6):83-92.
9
Skin cancer treatment options: new horizons and promises for the future.皮肤癌的治疗选择:新视野与未来展望
Wien Med Wochenschr. 2013 Aug;163(15-16):345-6. doi: 10.1007/s10354-013-0225-1.
10
[What's new in dermatological treatments?].[皮肤科治疗的新进展有哪些?]
Ann Dermatol Venereol. 2010 Dec;137 Suppl 4:S165-76. doi: 10.1016/S0151-9638(10)70043-0.

引用本文的文献

1
A computational multi-targeting approach for drug repositioning for psoriasis treatment.一种针对银屑病治疗的药物重定位的计算多靶方法。
BMC Complement Med Ther. 2021 Jul 5;21(1):193. doi: 10.1186/s12906-021-03359-2.

本文引用的文献

1
Indexed Pain Journals.索引疼痛期刊。
J Pain Palliat Care Pharmacother. 2008;22(1):45-46. doi: 10.1080/15360280801989377.
2
New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.银屑病和银屑病关节炎管理的新进展:聚焦阿普斯特
Drug Des Devel Ther. 2013;7:201-10. doi: 10.2147/DDDT.S32713. Epub 2013 Mar 27.
3
Small molecular compounds in development for rheumatoid arthritis.类风湿关节炎治疗药物的研发进展。
Curr Opin Rheumatol. 2013 May;25(3):391-7. doi: 10.1097/BOR.0b013e32835fd828.
4
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study.司库奇尤单抗诱导和维持治疗中重度斑块状银屑病:一项随机、双盲、安慰剂对照、Ⅱ期方案探索研究。
Br J Dermatol. 2013 Feb;168(2):402-11. doi: 10.1111/bjd.12112.
5
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study.司库奇尤单抗治疗中重度斑块状银屑病的疗效和安全性:一项随机、双盲、安慰剂对照的 II 期剂量范围研究。
Br J Dermatol. 2013 Feb;168(2):412-21. doi: 10.1111/bjd.12110. Epub 2013 Jan 18.
6
Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study.阿普米司特治疗中重度斑块状银屑病的疗效和安全性:一项 II 期、多中心、随机、双盲、安慰剂对照、平行分组、剂量比较研究的结果。
J Eur Acad Dermatol Venereol. 2013 Mar;27(3):e376-83. doi: 10.1111/j.1468-3083.2012.04716.x. Epub 2012 Oct 3.
7
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study.托法替尼治疗银屑病的疗效和安全性:一项 2b 期随机安慰剂对照剂量范围研究。
Br J Dermatol. 2012 Sep;167(3):668-77. doi: 10.1111/j.1365-2133.2012.11168.x.
8
Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial.阿普米司特治疗中重度银屑病的疗效:一项随机对照试验。
Lancet. 2012 Aug 25;380(9843):738-46. doi: 10.1016/S0140-6736(12)60642-4. Epub 2012 Jun 29.
9
Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.抗白细胞介素-17 单克隆抗体依奇珠单抗治疗慢性斑块状银屑病。
N Engl J Med. 2012 Mar 29;366(13):1190-9. doi: 10.1056/NEJMoa1109997.
10
Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.布罗达单抗,一种用于治疗银屑病的抗白细胞介素-17 受体抗体。
N Engl J Med. 2012 Mar 29;366(13):1181-9. doi: 10.1056/NEJMoa1109017.